EXACT SCIENCES CORP — Investor Relations & Filings

Exact Sciences Corp. is a molecular diagnostics company focused on eradicating cancer through prevention, early detection, and personalized treatment guidance. The company provides a portfolio of tests across the cancer care continuum, from assessing hereditary risk to screening and post-diagnosis treatment guidance. Its key products include Cologuard, a non-invasive, at-home screening test for colorectal cancer, and the Oncotype DX suite of genomic tests, which analyze tumor biology to inform personalized treatment decisions for cancers such as breast and prostate. By leveraging advanced science and technology, Exact Sciences aims to deliver critical insights that help patients and healthcare providers make more informed decisions and improve outcomes.